Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million - Novartis ( NYSE:NVS )
Novartis to acquire Regulus for $7/share upfront, a 108% premium to April 29 close and 274% over 60-day VWAP. The total deal could reach $1.7 billion if farabursen gains regulatory approval, with closing expected in H2 2025. Don't face extreme market conditions unprepared.
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
KUALA LUMPUR, Malaysia, April 30, 2025 ( GLOBE NEWSWIRE ) -- BioNexus Gene Lab Corp. ( Nasdaq: BGLC ) , a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it has received official notification from The Nasdaq Stock Market LLC ( ...
Western Digital Posts Better-Than-Expected Earnings, Joins Wingstop, Qorvo, Seagate And Other Big Stocks Moving Higher On Wednesday - Concord Medical Services ( NYSE:CCM ) , Cantor Equity Partners ( NASDAQ:CEP )
U.S. stocks were lower, with the Dow Jones index falling around 200 points on Wednesday. Shares of Western Digital Corporation WDC rose sharply during Wednesday's session after the company reported better-than-expected third-quarter adjusted EPS results and issued fourth-quarter adjusted EPS ...
Alibaba Launches 'Instant Commerce' Rapid-Delivery To Compete With Chinese E-Commerce Rivals - Alibaba Gr Hldgs ( NYSE:BABA )
Alibaba launches launched a new rapid-delivery feature on its Taobao shopping platform. The rapid-delivery service is a significant step in Alibaba's strategy to integrate its online marketplaces with its delivery network. Don't face extreme market conditions unprepared.
GE HealthCare Blames Tariffs For Lowering 2025 Profit Outlook, Initiates Stock Buyback - GE HealthCare Techs ( NASDAQ:GEHC )
Q1 EPS hit $1.01 vs. $0.90 last year and beat the $0.91 consensus; sales reached $4.78 billion, topping $4.66 billion expectations. Orders jumped 10% organically YoY; net income margin improved 380 bps to 11.8%, adjusted EBIT margin rose to 15.0%.
Annual Information of Amber Grid for 2024
On 30th April, 2025 during the Ordinary General Meeting of Amber Grid Shareholders audited Consolidated and separate financial statements and the consolidated annual report for year 2024 has been approved.
Prosafe SE: 2024 Annual report
30 April 2025 - Prosafe SE today published the Annual report, Transparency Act Statement and Remuneration report for 2024. The Annual report includes the 2024 annual accounts, corporate governance report and sustainability report.
Trump blames Biden 'overhang' after GDP shrinks in first quarter, says growth will 'take a while'
President Donald Trump blamed his predecessor and defended his sweeping tariffs after new data showed the U.S. economy contracting last quarter.
Britain's GSK Asserts It Is 'Well Positioned' To Mitigate Potential Tariffs After Strong Q1 Cancer And HIV Drug Sales - GSK ( NYSE:GSK )
GSK Q1 sales hit $9.46 billion, surpassing estimates of $7.46 billion; core EPS was $1.13 vs. $1.04 expected. Specialty Medicines rose 16% to £2.93 billion; Arexvy sales dropped 57% to £78 million on reduced ACIP recommendation. Today's manic market swings are creating the perfect setup for ...
Etsy 'Stays Nimble,' CEO Says As Revenue Grows, Active Buyers Decline - Etsy ( NASDAQ:ETSY )
Etsy's active buyers declined 3.4% to 88.5 million in Q1. Don't face extreme market conditions unprepared. Get the professional edge with Benzinga Pro's exclusive alerts, news advantage, and volatility tools at 60% ( discount ends Wednesday! )



















